WALKER WAYNE REMELL - Insider Non-Derivative Transactions at PharmaCyte Biotech, Inc. (PMCB) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 12, 2025, WALKER WAYNE REMELL's relationship to PharmaCyte Biotech, Inc. (PMCB) is Director, and currently has 37,500 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PMCB insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

WALKER WAYNE REMELL - Insider Non-Derivative Transactions of PMCB Common Stock

WALKER WAYNE REMELL - Insider Non-Derivative Transactions at PMCB

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 13, 2025	F -- (Common Stock)	16875	1.02	20625
Dec 13, 2025	Acquisition -- (Common Stock)	37500	0	37500